Case report of treatment experience with idursulfase beta (Hunterase) in an adolescent patient with MPS II

Mucopolysaccharidosis (MPS) II or Hunter syndrome is a chronic, progressive, multi-systemic illness associated with significant morbidity and early mortality. Available evidence in Asian populations shows that Hunter syndrome has a mean age of onset of 2 to 5 years and a life expectancy of 13 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngu, Lock-Hock, Ong Peitee, Winnie, Leong, Huey Yin, Chew, Hui Bein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432659/
https://www.ncbi.nlm.nih.gov/pubmed/28540187
http://dx.doi.org/10.1016/j.ymgmr.2017.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432659/
https://www.ncbi.nlm.nih.gov/pubmed/28540187
http://dx.doi.org/10.1016/j.ymgmr.2017.05.002

Ejemplares similares